Abstract

BackgroundIn our previous study, we found that the expression of adiponectin and adiponectin receptor 1 in synovial fluids and synovial tissues of patients with rheumatoid arthritis is higher than the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
MicroRNA-449 targets histone deacetylase 1 to regulate the proliferation, invasion, and apoptosis of synovial fibroblasts in rheumatoid arthritis.
Xuqing Cao ... Xiaoli Ma
Annals of palliative medicine | VOL. 10
Xuqing Cao, et. al.Xuqing Cao ... Xiaoli Ma
01 Jul 2021
Adiponectin mitigates the severity of arthritis in mice with collagen‐induced arthritis
Y‐B Park ... J‐H Kim
Scandinavian Journal of Rheumatology | VOL. 37
Y‐B Park, et. al.Y‐B Park ... J‐H Kim
01 Jan 2008
Activated protein C targets immune cells and rheumatoid synovial fibroblasts to prevent inflammatory arthritis in mice.
Meilang Xue ... Suat Dervish
Rheumatology (Oxford, England) | VOL. 58
Meilang Xue, et. al.Meilang Xue ... Suat Dervish
10 Jan 2019
Adiponectin aggravates bone erosion by promoting osteopontin production in synovial tissue of rheumatoid arthritis
Rui Liu ... Qin Wu
Arthritis Research & Therapy | VOL. 20
Rui Liu, et. al.Rui Liu ... Qin Wu
08 Feb 2018
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers